miR-1 inhibits progression of high-risk papillomavirus-associated human cervical cancer by targeting G6PD
Tao Hu(Kunming Medical University), Hua Jin(First People's Hospital of Yunnan Province), Yan‐Bin Xiyang(Kunming Medical University), Guang‐Cai Liu(Third People's Hospital of Yunnan Province), Rui Mao(Affiliated Hospital of Southwest Medical University), Ye-Fei Chang(Third People's Hospital of Yunnan Province), Zhangang Xiao(Southwest Medical University), Hong-Lan Chen(Third People's Hospital of Yunnan Province), Bo Chen(Hubei University of Medicine), Ying Hong(Third People's Hospital of Yunnan Province), Jun Tong(Kunming Medical University), Shuyi Kong(Kunming Medical University), Yanmei Huang(Third People's Hospital of Yunnan Province)
Cited by 36
Related Papers
VEGF/VEGFR-Targeted Therapy and Immunotherapy in Non-small Cell Lung Cancer: Targeting the Tumor Microenvironment
|International Journal of Biological Sciences|2022|226
LncRNA FAL1 promotes cell proliferation and migration by acting as a CeRNA of miR-1236 in hepatocellular carcinoma cells
|Life Sciences|2018|209
Circular RNA SAMD4A controls adipogenesis in obesity through the miR-138-5p/EZH2 axis
|Theranostics|2020|128
Chinese herbal medicines for treating ulcerative colitis via regulating gut microbiota-intestinal immunity axis
|Chinese Herbal Medicines|2023|88